Revlimid News and Research

RSS
Gero uses AI platform to identify potential anti-COVID-19 drugs

Gero uses AI platform to identify potential anti-COVID-19 drugs

Drug therapy may delay onset of myeloma symptoms, finds study

Drug therapy may delay onset of myeloma symptoms, finds study

Research offers hope for patients with serious bone marrow cancer

Research offers hope for patients with serious bone marrow cancer

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Trump vows (again) to lower drug prices but skeptics doubt much will change

Trump vows (again) to lower drug prices but skeptics doubt much will change

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

Study shows three-drug combination delays recurrence and lengthens life for myeloma patients

Maintenance lenalidomide treatment improves overall survival in multiple myeloma patients

Maintenance lenalidomide treatment improves overall survival in multiple myeloma patients

Clinical trial to test safety, efficacy of Roswell Park-developed SurVaxM in multiple myeloma patients

Clinical trial to test safety, efficacy of Roswell Park-developed SurVaxM in multiple myeloma patients

Yale study identifies how myeloma cells escape treatment

Yale study identifies how myeloma cells escape treatment

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Maintenance therapy with lenalidomide benefits patients with multiple myeloma

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

IMF announces approval of POMALYST medication in Canada for patients with myeloma

IMF announces approval of POMALYST medication in Canada for patients with myeloma

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting

ImmunoGen presents Phase I trial results of SAR650984 at ASH annual meeting